Trial Profile
A Phase 1/2a, Open-Label Study Evaluating the Pharmacokinetics, Safety and Tolerability of Luliconazole Solution, 10% in Subjects With Moderate to Severe Distal Subungual Onychomycosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Luliconazole (Primary)
- Indications Onychomycosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Topica Pharmaceuticals
- 21 May 2014 New trial record